Hope Tome E will find this and respond. I read your reply to YAMA " using SA". As suggested by you I read the recommendation on GILD and went to its board, not much here. so here are my questionswhy is GILD a buy now?Is it a growth stock and an innovator?Does it have a big moat?From the original rec, its revenue is from HIV drugs and 2 were waiting to be FDA approved. were they approved? ( quad, Btripla). From what I read on the posts there is some concern about the Hepc drug.So why is this a buy now.trying to learn.I haven't figured out the ticker guideThanks
Best Of |
Favorites & Replies |
Start a New Board |
My Fool |
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst Rat